Seeking men and women whose multiple sclerosis has not responded well to previous treatment and whose doctor has decided to start treatment with cladribine tablets and stop treatment with an injectable drug.
In this study researchers will collect data about the treatment that volunteers with relapsing multiple sclerosis and their doctors decide upon as part of their normal care. At times, volunteers will be asked to complete questionnaires about their health.
What we're hoping for
We hope to evaluate the effectiveness of the investigational drug on relapsing multiple sclerosis when used as part of routine care and to better understand treatment for relapsing multiple sclerosis
ClinicalTrials.gov Identifier: NCT03933215